Last reviewed · How we verify
Urinary incontinence
Approved treatments
- Banthine · Takeda
- Dl-Terodiline
- Urispas
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urinary incontinence patent landscape — cliff calendar, originator estates, attackable patents
- Urinary incontinence treatment landscape brief
- Urinary incontinence treatment updates RSS
Frequently asked questions about Urinary incontinence
What drugs treat Urinary incontinence?
Tracked treatments include Banthine, Dl-Terodiline, Urispas.
What is the treatment for Urinary incontinence?
Standard treatment for Urinary incontinence includes Banthine, Dl-Terodiline, Urispas. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urinary incontinence patent cliff · Urinary incontinence CI report
- Treatment: Banthine · Takeda
- Treatment: Dl-Terodiline
- Treatment: Urispas
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing